University of California Los Angeles - United States
Author Profile
Orcid
EARLY ACADEMIC PURSUITS:
Mario I. Vega initiated his academic journey at the Universidad Autónoma Metropolitana Campus Xochimilco, Mexico City, serving as a Research Technical Assistant in the Department of Leptospirosis Human Research from 1991 to 1992. He continued his research roles at the Hospital Infantil de Mexico "Federico Gomez" and the Instituto Mexicano del Seguro Social (IMSS) with a focus on immunology and infectious diseases.
PROFESSIONAL ENDEAVORS:
Mario I. Vega's professional trajectory includes positions at prestigious institutions, such as UCLA AIDS Institute and IMSS, where he advanced from Assistant Researcher to Professor in the field of tumor immunology and infectious diseases. Notably, he has been associated with UCLA Medical Center, Jonsson Comprehensive Cancer Center, contributing as Staff Associate Researcher in the Clinical Nutrition Division.
CONTRIBUTIONS AND RESEARCH FOCUS ON TUMOR IMMUNOLOGY:
Dr. Vega's research contributions span diverse areas, from rituximab inhibition of p38 MAPK activity in B NHL to extensive work in immunology, cancer, and infectious diseases. His research expertise includes molecular biology, DNA replication, PCR, and immunotherapy. Serving on various review committees and editorial boards, he has actively contributed to scientific evaluations and publications.
IMPACT AND INFLUENCE:
Dr. Mario I. Vega's impact is evident through numerous honors and awards, such as the American Society of Hematology (ASH) Travel Award in 2004 and consecutive Fogarty fellowships at UCLA from 2004 to 2013. His recognition extends to national and international awards in pediatric research, biomedical research, and contributions to scientific journals.
ACADEMIC CITES:
Dr. Vega has left a mark on academia with memberships in esteemed organizations like ASH, AACR, and AAI. His participation in teaching activities, including courses on molecular biology, immunology, and cancer, demonstrates his commitment to knowledge dissemination.
LEGACY AND FUTURE CONTRIBUTIONS:
This overview highlights Dr. Mario I. Vega's academic and professional journey, his substantial contributions to medical research, and the potential impact of his continued work on the fields of immunology and oncology.
Notable Publications
Regulation of Krüppel-Like Factor 4 (KLF4) expression through the transcription factor Yin-Yang 1 (YY1) in non-Hodgkin B-cell lymphoma.2019
Role of MicroRNA-7 (MiR-7) in Cancer Physiopathology.2022
Roles and Regulation of BCL-xL in Hematological Malignancies.2022